introduct
inovirusassoci
vector
iav
deriv
bacteri
filament
virus
phage
vaccin
carrier
elicit
cellular
humor
respons
varieti
pathogen
caus
infecti
diseas
noninfecti
diseas
display
specif
antigen
epitop
protein
coat
protein
iav
merit
much
studi
uniqu
abil
exploit
widespread
vaccin
develop
area
cover
architectur
trait
filament
virus
deriv
iav
facilit
display
specif
antigen
peptid
induc
antibodi
product
prevent
curtail
infect
inovirus
provid
foundat
costeffici
largescal
specif
phage
display
paper
develop
differ
applic
inovirusbas
phage
display
vaccin
across
broad
rang
pathogen
host
review
refer
cite
review
select
establish
databas
base
author
knowledg
studi
subject
expert
commentari
import
phagedisplay
technolog
recent
highlight
nobel
prize
chemistri
award
georg
p
smith
sir
gregori
p
winter
furthermor
symbiot
natur
filament
virus
infect
intestin
f
e
coli
strain
offer
attract
platform
develop
novel
vaccin
stimul
mucos
immun
articl
histori
research
regard
potenti
use
virus
combat
diseas
ongo
year
virus
often
consid
pernici
coopt
host
surviv
often
kill
host
process
new
work
virus
exploit
bacteriophag
without
harm
effect
arisen
virus
easili
manipul
employ
phage
display
abil
increasingli
use
varieti
potent
biomed
tool
filament
bacteri
virus
make
genu
inoviru
famili
inovirida
threadlik
virus
contain
singlestrand
dna
genom
know
filament
bacteriophag
differ
speci
filament
virus
known
major
infect
gramneg
bacteria
although
inovirus
use
phage
display
capabl
filament
virus
relationship
cell
infect
similar
symbiot
nonpathogen
anim
virus
classic
phage
unlik
phage
term
come
greek
word
destroy
inovirus
kill
host
slightli
affect
cell
growth
despit
yield
titer
virion
per
millilit
liquid
cultur
progeni
virion
assembl
host
cell
membran
singlestrand
dna
bind
protein
replac
major
capsid
protein
subunit
releas
cell
result
opaqu
plaqu
bacteri
lawn
receptor
organel
bacteri
host
encod
transmiss
plasmid
facilit
interact
inoviru
cell
function
architectur
inovirus
provid
foundat
applic
vaccinerel
project
sinc
inovirus
caus
harm
great
number
inoviru
speci
across
world
isol
character
despit
variat
speci
gener
physic
characterist
virion
flexibl
thin
cylindr
filament
nm
diamet
approxim
nm
length
see
figur
detail
singl
virion
compos
sever
thousand
major
capsid
coat
protein
subunit
surround
circular
singlestrand
dna
molecul
proxim
end
virion
minor
protein
attach
cell
initi
infect
distal
end
minor
protein
use
nucleat
assembl
host
membran
structur
life
cycl
conserv
across
differ
speci
inovirus
result
similar
function
applic
research
inoviru
structur
applic
domin
studi
ff
infect
male
f
strain
e
coli
use
best
understood
ff
inovirus
close
relat
fd
type
review
see
extens
inform
regard
life
cycl
genet
known
nearli
ident
virus
almost
perfectli
share
structur
motif
includ
dna
protein
sequenc
gene
organ
although
slight
variat
genom
gene
noncod
intergen
region
conserv
across
ff
speci
well
dna
replic
transcript
machineri
recent
review
see
protein
encod
gene
virion
gene
protein
major
coat
protein
make
vast
major
virion
occur
fivefold
axial
symmetri
gene
protein
locat
proxim
end
virion
involv
stabil
infect
host
cell
gene
protein
distal
end
virion
perform
initi
assembl
shown
endtoend
model
figur
minor
coat
protein
subunit
fivefold
axial
symmetri
much
research
done
structur
ff
viru
past
year
conclus
structur
determin
sinc
virus
crystal
xray
fiber
diffract
studi
physiochem
measur
reveal
fivestar
helic
symmetri
rotat
axi
subunit
refer
class
howev
structur
ssdna
relationship
protein
sheath
poorli
understood
due
small
amount
dna
individu
virion
howev
architectur
suffici
understood
take
advantag
structur
capabl
viru
throughout
life
cycl
life
cycl
ff
filament
virus
begin
adsorpt
structur
proxim
end
viru
adsorb
tip
f
specif
pilu
e
coli
follow
bind
viru
bacteri
cell
recent
review
see
major
coat
protein
articl
highlight
inovirus
easili
manipul
virus
coexist
host
caus
minim
harm
highli
reproduc
simpl
genet
manipul
make
insert
random
specif
oligonucleotid
inoviru
genom
genet
modifi
inovirus
display
correspond
oligopeptid
fusion
protein
surfac
refer
inovirusassoci
vector
iav
iav
display
randomli
gener
oligopeptid
use
identifi
epitop
specif
antibodi
biopan
isol
recombin
inovirus
display
mimotyp
resembl
antibodi
discontinu
target
epitop
dna
amino
acid
sequenc
oligopeptid
interest
determin
iav
bene
use
creat
vaccin
varieti
infecti
noninfecti
diseas
use
screen
immunogen
peptid
directli
present
immunogen
peptid
organ
elicit
proper
antibodi
product
iav
highli
immunogen
stimul
humor
cellular
respons
varieti
diseas
pose
known
health
risk
costeffici
produc
box
summar
key
point
contain
articl
viru
becom
associ
inner
membran
cell
virion
circular
singlestrand
dna
cssdna
eject
cytoplasm
convert
parent
doublestrand
replic
form
rf
use
rollingcircl
mechan
ff
inovirus
replic
genom
new
virion
assembl
complex
set
interact
bind
protein
subunit
ssdna
emb
newli
synthes
coat
protein
bacteri
membran
ssdna
pass
matur
coat
protein
span
bacteri
membran
addit
coat
protein
ad
intern
edg
membran
addit
protein
use
packag
inoviru
releas
cell
inoviru
assembl
inner
membran
bacteria
harmon
sequenti
process
viralencod
host
protein
play
import
role
extens
review
inoviru
life
cycl
replic
see
review
importantli
process
requir
viru
host
complet
kill
host
make
inoviru
replic
sustain
process
inovirus
use
vaccin
develop
possibl
insert
random
oligonucleotid
genom
easi
genet
manipul
basi
inoviru
display
phage
display
technolog
inovirus
genet
modifi
display
oligopeptid
fusion
protein
surfac
refer
inovirusassoci
vector
iav
oligopeptid
display
capsid
protein
follow
genet
modif
specif
oligonucleotid
sequenc
insert
viral
genom
display
desir
oligopeptid
fusion
capsid
protein
result
oligopeptid
display
everi
copi
target
capsid
protein
howev
mosaic
inoviru
particl
creat
specif
capsid
protein
display
mix
wild
type
recombin
protein
desir
oligopeptid
done
use
phagemid
vector
extra
copi
capsid
protein
fuse
specif
oligonucleotid
host
expos
phagemid
vector
wild
type
capsid
protein
defici
helper
phage
produc
mosaic
iav
display
wild
type
oligopeptid
fuse
capsid
protein
work
use
capsid
protein
result
product
mosaic
iav
review
see
mosaic
nonmosa
iav
produc
use
review
see
review
see
result
differ
locat
structur
abund
capsid
protein
iav
differenti
abil
display
differ
oligopeptid
figur
b
show
five
capsid
protein
iav
display
antigen
demonstr
publish
literatur
capsid
protein
display
copi
desir
oligopeptid
due
larg
amount
inoviru
nonmosa
iav
display
peptid
approxim
copi
howev
larg
peptid
distort
viru
peptid
amino
acid
display
great
quantiti
without
affect
structur
inoviru
howev
produc
mosaic
iav
oligopeptid
far
fewer
unit
caus
distort
theoret
possibl
display
entir
protein
present
copi
per
virion
studi
demonstr
one
copi
display
desir
protein
abil
iav
display
differ
random
oligopeptid
surfac
mani
applic
especi
use
vaccin
develop
creation
random
peptid
librari
rpl
random
oligopeptid
fuse
major
capsid
protein
display
individu
inoviru
clone
creat
random
varieti
iav
use
vaccin
design
via
epitop
map
use
monoclon
polyclon
antibodi
random
iav
whose
oligopeptid
divers
increas
increas
peptid
length
use
identifi
epitop
specif
antibodi
process
call
biopan
allow
isol
iav
display
mimotop
mimic
antibodi
discontinu
target
epitop
isol
recombin
inovirus
bear
mimotop
dna
amino
acid
sequenc
oligopeptid
interest
determin
breakthrough
technolog
subject
matter
nobel
prize
chemistri
see
expert
commentari
inovrius
display
oligopeptid
mimick
antigen
specif
epitop
antigen
use
vaccin
host
thu
induc
desir
antibodi
product
vaccin
sort
develop
varieti
organ
mani
differ
diseas
see
tabl
list
inovirusbas
vaccin
introduct
inovirus
induc
product
specif
antibodi
alreadi
variou
success
method
potenti
open
door
develop
mani
novel
vaccin
vaccin
methodolog
iav
success
use
vaccin
carrier
varieti
speci
diseas
across
rang
vaccin
studi
shown
vaccin
effect
infect
agent
viral
protozoan
worm
parasit
well
noninfecti
diseas
includ
alzheim
varieti
cancer
inoviru
display
technolog
use
two
differ
way
develop
vaccin
first
method
employ
inoviru
display
technolog
screen
rpl
monoclon
antibodi
determin
peptid
use
immunogen
peptid
use
vaccin
either
carrier
protein
solubl
form
elicit
immun
respons
second
method
employ
inovirus
epitop
map
also
util
inovirus
serv
carrier
isol
immunogen
peptid
directli
use
iav
present
peptid
consist
success
produc
product
proper
antibodi
introduct
solubl
peptid
inovirusbound
peptid
iav
consist
retain
structur
stabl
solubl
peptid
alway
reflect
desir
antigen
epitop
iav
structur
simpl
allow
immun
system
respond
fuse
peptid
rather
viral
coat
combin
abil
display
mani
copi
desir
peptid
iav
highli
immunogen
creat
effect
vaccin
inovirus
replic
e
coli
cultur
product
larg
number
vaccin
costeffici
iav
structur
simplic
high
immunogen
econom
product
make
effici
attain
system
creat
varieti
effect
vaccin
much
research
involv
inovirusbas
vaccin
target
infecti
diseas
anim
studi
shown
iav
construct
protect
vaccin
anim
varieti
infecti
diseas
elicit
humor
cellular
immun
respons
test
efficaci
iav
vaccin
target
pathogen
studi
conduct
anim
challeng
specif
pathogen
follow
iav
vaccin
studi
iav
shown
mitig
prevent
infect
virus
parasit
one
studi
mice
complet
vaccin
human
respiratori
syncyti
viru
rsv
bind
linear
epitop
induc
humor
respons
monoclon
antibodi
variou
viral
diseas
also
success
screen
rpl
produc
recombin
inoviru
vaccin
herp
simplex
viru
type
use
peptid
neurotrop
murin
coronaviru
sing
peptid
inoviru
vaccin
induc
humor
respons
mice
greatli
reduc
mortal
provid
protect
rel
dose
vaccin
iav
vaccin
also
develop
fungal
parasit
anim
provid
individu
protect
larg
scale
vaccin
success
vaccin
lower
burden
infect
also
increas
lifespan
infect
mice
manoutsarian
et
al
use
iav
vaccin
pig
taenia
solium
parasit
worm
caus
neurocysticercosi
human
use
pig
intermedi
host
unlik
previou
studi
use
singl
specif
peptid
fuse
inoviru
four
differ
antigen
peptid
display
inovirus
cocktail
recombin
iav
induct
cellular
respons
complet
vaccin
pig
studi
reduc
number
cysticerci
pig
follow
success
studi
largescal
vaccin
pig
mexico
undertaken
pig
natur
environ
success
immun
reduc
parasit
presenc
vaccin
pig
provid
costeffici
altern
vaccin
synthet
peptid
mani
addit
vaccin
develop
induc
humor
cellular
respons
parasit
anim
provid
partial
protect
infect
reduc
infect
burden
mani
studi
done
screen
monoclon
polyclon
antibodi
larg
rpl
review
inoviru
vaccin
studi
see
addit
success
infecti
diseas
inoviru
display
technolog
success
use
design
vaccin
prevent
mitig
progress
noninfecti
diseas
iav
use
display
antigen
epitop
elicit
immun
respons
tumor
noninfecti
diseas
epitop
melanoma
antigen
mage
display
induc
cellular
immun
respons
melanoma
tumor
vaccin
mice
vaccin
inhibit
tumor
growth
reduc
mortal
target
mice
induct
cellular
respons
decreas
tumor
growth
higher
surviv
rate
observ
mice
vaccin
murin
mastocytoma
later
studi
highli
immunogen
characterist
inoviru
display
technolog
also
use
activ
immun
respons
colorect
cancer
tumor
often
evad
antitumor
immun
respons
reduc
tumor
growth
inovirusbas
vaccin
also
use
diseas
alzheim
method
use
induct
antibodi
plaqu
display
specif
amino
acid
antigen
epitop
surfac
inoviru
multipl
studi
mice
use
recombin
inovirus
induc
humor
respons
reduc
plaqu
burden
use
prevent
done
infecti
diseas
iav
vaccin
anim
diseas
progress
noninfecti
diseas
find
suggest
futur
develop
inovirusbas
vaccin
noninfecti
diseas
mitig
damag
done
anim
human
despit
advanc
use
iav
combat
diseas
consist
develop
inovirusbas
vaccin
still
face
challeng
even
inovirus
screen
specif
antibodi
bear
desir
peptid
mimotop
immun
use
iav
alway
produc
expect
immun
respons
keller
et
al
unabl
induc
product
broadli
neutral
antibodi
human
immunodefici
viru
rabbit
despit
screen
proper
mimotop
dorgham
et
al
screen
rpl
use
broadli
neutral
antibodi
use
select
inovirus
abl
induc
antibodi
vaccin
mice
howev
induc
antibodi
exhibit
neutral
activ
rpl
screen
monoclon
broadli
neutral
antibodi
produc
antibodi
neutral
capabl
one
case
crystal
specif
mimotop
reveal
oligopeptid
born
inoviru
structur
differ
natur
antibodi
epitop
structur
issu
like
foundat
mani
issu
involv
ineffectu
inovirusbas
vaccin
iav
fail
probabl
chosen
mimotop
poorli
resembl
origin
antibodi
epitop
function
desir
fashion
either
fail
induc
antibodi
induc
antibodi
without
neutral
capabl
despit
efficaci
inovirusbas
vaccin
varieti
infecti
noninfecti
diseas
still
mani
diseas
effect
vaccin
develop
use
phage
display
method
exampl
discuss
despit
extens
work
inovirus
begin
keller
et
al
littl
success
develop
vaccin
four
major
epitop
envelop
glycoprotein
identifi
induc
product
effect
antibodi
success
current
techniqu
succeed
humor
cellular
respons
inovirusbas
vaccin
research
howev
groundwork
futur
work
involv
diseas
laid
pave
way
multitud
variou
new
inovirusbas
vaccin
mani
vaccin
studi
target
use
iav
none
complet
success
studi
involv
inoviru
basedvaccin
target
initi
use
broadli
neutral
monoclon
antibodi
howev
discuss
studi
either
fail
induc
antibodi
induc
nonneutr
antibodi
despit
often
induc
humor
respons
studi
polyclon
sera
individu
use
screen
rpl
search
new
broadli
neutral
monoclon
antibodi
studi
use
iav
induc
protect
neutral
antibodi
mice
macaqu
simianhuman
immunodefici
viru
inovirusbas
vaccin
target
abl
control
viral
load
varieti
nonhuman
mammal
challeng
induc
neutral
antibodi
inhibit
novel
infect
induc
broadli
neutral
antibodi
addit
inovirusbas
vaccin
often
fail
due
autoreact
monoclon
antibodi
hope
avoid
new
next
gener
broadli
neutral
antibodi
inovir
vector
use
extens
develop
vaccin
varieti
infecti
noninfecti
diseas
past
two
decad
shown
iav
success
induc
humor
cellular
respons
studi
vaccin
could
provid
partial
complet
protect
pathogen
caus
infecti
diseas
mere
lower
burden
infect
noninfecti
diseas
inovirusbas
vaccin
shown
effect
mitig
diseas
develop
initi
product
immun
respons
alreadi
mani
applic
vaccin
infecti
noninfecti
diseas
use
inovir
vector
iav
distinct
characterist
make
applic
develop
new
vaccin
viral
vector
inovirus
extent
iav
highli
immunogen
requir
adjuv
facilit
eas
simplic
usag
vaccin
display
multipl
thousand
copi
peptid
surfac
still
maintain
desir
structur
conform
well
infect
bacteri
host
iav
display
particular
peptid
allow
immun
system
interact
specif
epitop
rather
larger
complex
protein
yield
target
respons
capabl
stimul
humor
cellular
immun
respons
pose
known
health
risk
anim
human
iav
administ
safe
high
dose
multipl
rout
enhanc
usag
varieti
context
costeffici
product
structur
simplic
record
success
varieti
context
iav
potenti
exploit
mani
new
vaccin
human
anim
varieti
diseas
advanc
inoviru
research
phage
display
technolog
make
develop
new
vaccin
varieti
diseas
feasibl
near
futur
current
mani
diseas
without
vaccin
treatment
highli
invas
develop
involv
iav
like
introduc
better
increasingli
costeffect
vaccin
structur
tool
genet
manipul
inovirus
better
develop
iav
like
begin
extens
introduc
anim
human
use
current
research
reveal
tip
iceberg
extens
way
inovirusbas
vaccin
appli
futur
use
accordingli
aspect
genet
engin
phagedisplay
need
expand
specif
studi
conduct
evalu
maximum
antigen
load
capac
coat
protein
without
jeopard
architectur
integr
infect
iav
see
figur
furthermor
addit
research
potenti
use
capsid
protein
combin
capsid
protein
antigen
display
need
addit
futur
studi
could
elucid
nuanc
use
individu
capsid
protein
special
applic
antigen
display
penetr
target
etc
addit
aspect
iav
need
explor
antigen
display
surfac
iav
induc
immunogen
predict
work
need
undertaken
experiment
comput
silico
research
research
involv
develop
new
vaccin
improv
efficaci
current
vaccin
addit
undertak
done
identifi
structur
virus
sinc
better
abl
inform
phagedisplay
technolog
best
appli
complex
work
done
use
monoclon
polyclon
antibodi
creat
nuanc
vaccin
futur
dual
focu
develop
vaccin
infecti
diseas
induct
immun
respons
noninfecti
diseas
limit
harm
elimin
underli
principl
futur
iavbas
vaccin
develop
could
base
uniqu
natur
symbiosi
known
exist
human
nonpathogen
bacteria
e
coli
inovirus
well
establish
human
warmblood
anim
acquir
ecoli
includ
f
strain
first
day
life
even
birth
never
thereaft
without
fspecif
inovirus
ff
inovirus
infect
human
propag
high
viral
load
specif
strain
e
coli
includ
nonpathogen
strain
symbiot
human
futur
iavbas
vaccin
within
next
five
ten
year
could
take
advantag
tripl
symbiot
natur
human
enter
f
e
coli
strain
fspecif
inovirus
target
induct
mucos
immun
approach
particularli
effect
sexual
transmit
pathogen
much
futur
studi
lie
develop
iav
induc
immun
respons
broad
scale
research
regard
develop
advantag
phage
display
technolog
recent
recogn
nobel
committe
georg
p
smith
gregori
p
winter
award
nobel
prize
chemistri
eleg
method
known
phage
display
bacteriophagea
viru
infect
bacteriacan
use
evolv
new
protein
revolut
bring
bring
greatest
benefit
humankind
develop
better
inovirusbas
vaccin
continu
advanc
prevent
treatment
diseas
abl
combat
